River Front Investment Group, LLC Bristol Myers Squibb CO Transaction History
River Front Investment Group, LLC
- $5.47 Billion
- Q3 2025
A detailed history of River Front Investment Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, River Front Investment Group, LLC holds 19,838 shares of BMY stock, worth $928,616. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,838
Previous 6,853
189.48%
Holding current value
$928,616
Previous $317,000
182.02%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,692Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...